386 related articles for article (PubMed ID: 33241658)
21. Theoretical Study of the Molecular Mechanism of Maxingyigan Decoction Against COVID-19: Network Pharmacology-based Strategy.
Wang M; Fu D; Yao L; Li J
Comb Chem High Throughput Screen; 2021; 24(2):294-305. PubMed ID: 32767929
[TBL] [Abstract][Full Text] [Related]
22. Clinical characterization and therapeutic targets of vitamin A in patients with hepatocholangiocarcinoma and coronavirus disease.
Liang X; Zhou R; Li Y; Yang L; Su M; Lai KP
Aging (Albany NY); 2021 Jun; 13(12):15785-15800. PubMed ID: 34176789
[TBL] [Abstract][Full Text] [Related]
23. Study on the mechanism of treating COVID-19 with Shenqi Wan based on network pharmacology.
Ye XW; Deng YL; Zhang X; Liu MM; Liu Y; Xie YT; Wan Q; Huang M; Zhang T; Xi JH; Zhang JL
Drug Dev Ind Pharm; 2021 Aug; 47(8):1279-1289. PubMed ID: 34605344
[TBL] [Abstract][Full Text] [Related]
24. Potential mechanism underlying the effect of matrine on COVID-19 patients revealed through network pharmacological approaches and molecular docking analysis.
Peng W; Xu Y; Han D; Feng F; Wang Z; Gu C; Zhou X; Wu Q
Arch Physiol Biochem; 2023 Feb; 129(1):253-260. PubMed ID: 32915649
[TBL] [Abstract][Full Text] [Related]
25. Therapeutic targets and molecular mechanism of calycosin for the treatment of cerebral ischemia/reperfusion injury.
Yu S; Wu K; Liang Y; Zhang H; Guo C; Yang B
Aging (Albany NY); 2021 Jun; 13(12):16804-16815. PubMed ID: 34176787
[TBL] [Abstract][Full Text] [Related]
26. Modeling Kaempferol as a Potential Pharmacological Agent for COVID-19/PF Co-Occurrence Based on Bioinformatics and System Pharmacological Tools.
Jiang Y; Xie YZ; Peng CW; Yao KN; Lin XY; Zhan SF; Zhuang HF; Huang HT; Liu XH; Huang XF; Li H
Front Pharmacol; 2022; 13():865097. PubMed ID: 35754492
[No Abstract] [Full Text] [Related]
27. Preclinical
Li Y; Chen Y; Wei M; Wei C
Front Endocrinol (Lausanne); 2022; 13():845404. PubMed ID: 35464051
[TBL] [Abstract][Full Text] [Related]
28. Bioinformatics and
Qin J; Guo C; Yang L; Liang X; Jiao A; Lai KP; Yang B
Bioengineered; 2021 Dec; 12(2):12461-12469. PubMed ID: 34931923
[TBL] [Abstract][Full Text] [Related]
29. Puerarin protects rat kidney from lead-induced apoptosis by modulating the PI3K/Akt/eNOS pathway.
Liu CM; Ma JQ; Sun YZ
Toxicol Appl Pharmacol; 2012 Feb; 258(3):330-42. PubMed ID: 22172631
[TBL] [Abstract][Full Text] [Related]
30. Therapeutic Mechanism of Xiaoqinglong Decoction against COVID-19 Based on Network Pharmacology and Molecular Docking Technology.
Li HL; Zhou JP; Deng JM
Comb Chem High Throughput Screen; 2022; 25(13):2264-2277. PubMed ID: 35227178
[TBL] [Abstract][Full Text] [Related]
31. Bioactive Components of
Yuan H; Liu L; Zhou J; Zhang T; Daily JW; Park S
J Med Food; 2022 Apr; 25(4):355-366. PubMed ID: 35438554
[TBL] [Abstract][Full Text] [Related]
32. Investigating the active compounds and mechanism of HuaShi XuanFei formula for prevention and treatment of COVID-19 based on network pharmacology and molecular docking analysis.
Wang J; Ge W; Peng X; Yuan L; He S; Fu X
Mol Divers; 2022 Apr; 26(2):1175-1190. PubMed ID: 34105049
[TBL] [Abstract][Full Text] [Related]
33. Puerarin protects mouse liver against nickel-induced oxidative stress and inflammation associated with the TLR4/p38/CREB pathway.
Liu CM; Ma JQ; Liu SS; Feng ZJ; Wang AM
Chem Biol Interact; 2016 Jan; 243():29-34. PubMed ID: 26607348
[TBL] [Abstract][Full Text] [Related]
34. Identifying the molecular targets and mechanisms of xuebijing injection for the treatment of COVID-19 via network parmacology and molecular docking.
Tianyu Z; Liying G
Bioengineered; 2021 Dec; 12(1):2274-2287. PubMed ID: 34077310
[TBL] [Abstract][Full Text] [Related]
35. Anti-colorectal cancer biotargets and biological mechanisms of puerarin: Study of molecular networks.
Li J; Guo C; Lu X; Tan W
Eur J Pharmacol; 2019 Sep; 858():172483. PubMed ID: 31233753
[TBL] [Abstract][Full Text] [Related]
36. A Critical Review on Anticancer Mechanisms of Natural Flavonoid Puerarin.
Murahari M; Singh V; Chaubey P; Suvarna V
Anticancer Agents Med Chem; 2020; 20(6):678-686. PubMed ID: 32106804
[TBL] [Abstract][Full Text] [Related]
37. Network pharmacology study on the mechanism of the herb pair of prepared Rehmannia root-Chinese arborvitae kernel for anxiety disorders.
Liu PL; Song AR; Dong CD; Chu Q; Xu BL; Liu JM; Yan ZJ
Ann Palliat Med; 2021 Mar; 10(3):3313-3327. PubMed ID: 33849116
[TBL] [Abstract][Full Text] [Related]
38. Identification of the active compounds and their mechanisms of medicinal and edible Shanzha based on network pharmacology and molecular docking.
Pei H; Wu S; Zheng L; Wang H; Zhang X
J Food Biochem; 2022 Jan; 46(1):e14020. PubMed ID: 34825377
[TBL] [Abstract][Full Text] [Related]
39. Puerarin suppresses production of nitric oxide and inducible nitric oxide synthase in lipopolysaccharide-induced N9 microglial cells through regulating MAPK phosphorylation, O-GlcNAcylation and NF-κB translocation.
Zheng GM; Yu C; Yang Z
Int J Oncol; 2012 May; 40(5):1610-8. PubMed ID: 22246431
[TBL] [Abstract][Full Text] [Related]
40. Network pharmacology and molecular docking analyses on Lianhua Qingwen capsule indicate Akt1 is a potential target to treat and prevent COVID-19.
Xia QD; Xun Y; Lu JL; Lu YC; Yang YY; Zhou P; Hu J; Li C; Wang SG
Cell Prolif; 2020 Dec; 53(12):e12949. PubMed ID: 33140889
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
